Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
Top Cited Papers
Open Access
- 1 February 2008
- journal article
- practice guideline
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 46 (3), 327-360
- https://doi.org/10.1086/525258
Abstract
Aspergillus species have emerged as an important cause of life-threatening infections in immunocompromised patients. This expanding population is composed of paKeywords
This publication has 302 references indexed in Scilit:
- Multiple-Triazole–Resistant AspergillosisNew England Journal of Medicine, 2007
- Primary Invasive Aspergillosis of the Digestive Tract: Report of Two Cases and Review of the LiteratureInfection, 2006
- Liposomal amphotericin B as antifungal prophylaxis in bone marrow transplant patientsAmerican Journal of Hematology, 2006
- Spinal aspergillus vertebral osteomyelitis with extradural abscess: case report and review of literatureSurgical Neurology, 2004
- Bifidobacterium lipoteichoic acid and false ELISA reactivity in aspergillus antigen detectionThe Lancet, 2004
- Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazoleClinical and Experimental Dermatology, 2001
- Amphotericin B prophylaxis against invasive fungal infections in neutropenic patients: A single center experience from 1980 to 1995Infection, 1996
- Oral itraconazole plus nasal amphotericin B for prophylaxis of invasive aspergillosis in patients with hematological malignanciesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agentsDiagnostic Microbiology and Infectious Disease, 1992
- Itraconazole therapy in aspergillosis: Study in 49 patientsJournal of the American Academy of Dermatology, 1990